Advertisement

Topics

Latest "CanniMed Therapeutics Newstrike Resources" News Stories

22:22 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "CanniMed Therapeutics Newstrike Resources" found in our extensive news archives from over 250 global news sources.

More Information about CanniMed Therapeutics Newstrike Resources on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about CanniMed Therapeutics Newstrike Resources for you to read. Along with our medical data and news we also list CanniMed Therapeutics Newstrike Resources Clinical Trials, which are updated daily. BioPortfolio also has a large database of CanniMed Therapeutics Newstrike Resources Companies for you to search.

Showing "CanniMed Therapeutics Newstrike Resources" News Articles 1–25 of 10,000+

Extremely Relevant

#Cannabisstocks: Newstrike Brands Ltd. (TSX-V: $HIP.V) - Up Cannabis Announces Supply Agreement with Nova Scotia Liquor Corporation

TORONTO - August 24, 2018 (Investorideas.com Newswire) Newstrike Brands Ltd. (TSX-V:HIP) ("Newstrike" or the "Company"), is pleased to announce that Up Cannabis Inc. ("Up Cannabis"), its wholly-owned subsidiary, has been selected by the Nova Scotia Liquor Corporation ("NSLC") as one of fourteen licensed producers who have received initial purchase orders for adult-use cannabis.


Relevant

Up Cannabis Signs Supply Agreement with MediPharm Labs for Extraction

Newstrike Brands Ltd. (TSXV:HIP) ("Newstrike"), is pleased to announce its wholly-owned subsidiary Up Cannabis Inc. ("Up Cannabis"), has entered into a supply agreement with MediPharm Labs Inc. ("MediPharm Labs"), pursuant to which Up Cannabis will supply MediPharm Labs with a total of up to 1,200 kg of excess cannabis product in the form of flower and shake that will be used for the purposes of...

Where Is Aurora Cannabis Stock Heading With Each of These Acquisitions?

Aurora Cannabis Inc Stock 2019 Aurora Cannabis Inc (NYSE:ACB) has announced a number of blockbuster acquisitions since 2018, snapping up CanniMed Therapeutics Inc., MedReleaf Corp., ICC Labs Inc., ...


ACME Resources Announces Rapid Dose Therapeutics Signs a Definitive Agreement with Chemesis International

Toronto and Burlington, Ontario--(Newsfile Corp. - October 12, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT"), a bio-technology company focused on i...

Rapid Dose Therapeutics Announces Agreement with Chemesis International to License QuickStrip Technology in Puerto Rico

Toronto and Burlington, Ontario--(Newsfile Corp. - November 7, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT's Uni...

ZYUS and Up Cannabis Sign Definitive Supply Agreement

ZYUS Life Sciences Inc. (“ZYUS”) and Up Cannabis Inc. (“Up Cannabis”), a wholly-owned subsidiary of Newstrike Brands Ltd. (TSX-V: HIP) (“Newstrike”), are pleased to announce that they have entered into a definitive Supply Agreement (the “Agreement”) for ZYUS to purchase dried bulk cannabis from Up Cannabis. Up Cannabis will supply ...

Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria

Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria"...

Cedilla Therapeutics Expands Leadership Team with Appointment of Chief Human Resources Officer

Cedilla Therapeutics, a biotechnology company broadening the reach of small molecule therapeutics by discovering and exploiting unique insights into protein stability, today announced the appointment of a veteran biopharma executive, Andrew Dawson, as chief human resources officer. Dawson brings a wealth of

Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing

Sorrento Therapeutics (NASDAQ:SRNE) that its majority-owned subsidiary, Scilex Pharmaceuticals, closed a debt financing with leading global institutional investors for aggregate gross proceeds to Scilex of $140 million. As quoted in the press release: “This non-dilutive financing provides Scilex with the capital resources to successfully execute on the launch of ZTlido,” said Henry Ji, Chairma...

MOD Resources (MOD) - Sandfire’s bid undervalues MOD

Edison Investment Research - Mining - MOD Resources: MOD Resources has raised A$10m through an oversubscribed institutional placing at a price of A$0.30/share (17p/share), a 36% premium to the closing price on 18 January 2019. The company also intends to raise a further A$5m through a fully underwritten rights issue at A$24/share (13p/share). In addition, the company has received an unsolicited, n...

Entrée Resources (ETG) - Termination of coverage

Edison Investment Research - Mining - Entree Resources: Edison Investment Research is terminating coverage on Entrée Resources (ETG). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: CA29384J1030

PolyU - China Resources Plan to Establish Joint Research Centres

(PRWEB) November 16, 2018 The Hong Kong Polytechnic University (PolyU) reached strategic collaborative research framework agreements with China Resources Microelectronics Limited (CR Micro) and China Resources Life Science Industry Development Co., Ltd. (CR Life Science) respectively to explo...

Volt Resources (VRC) - Termination of coverage

Edison Investment Research - Mining - Volt Resources : Edison Investment Research is terminating coverage on Volt Resources (VRC). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.ISIN: AU000000VRC9

#jobs #lifescience Sr Human Resources Business Partner

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sr Human Resources Business Partner .NY-New York, job summary: Division: Human Resources/Corporate Division Reports to:Senior Director, Global HR Business Partners Job Duration: 6 months Bill rate: Max $130 … Continue reading → Cet article #jobs #lifescience Sr Hum...

Vascular Biogenics posts 2Q earnings beat; says it has enough resources for three years

The company reports an earnings loss, but has enough resources to fund operations

Roche’s Genentech agrees to buy Jecure Therapeutics

Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CEO The post Roche’s Genentech agrees to buy Jecure Therapeutics appeared first on Pharmaceutical Business review.

Health and Medical Resources Directory

Just ran across this nice Health and Medical Resources Directory. They say: This Healthcare Resources directory provides over ten thousand links to healthcare providers, physicians, medical centers, hospital and other health related services. It’s missing a search engine but otherwise it’s pretty nice.

Nine essential resources for preregistration trainees

Resources preregistration trainee pharmacists should be aware of and know how to use.

#jobs #lifescience Kelly Scientific Resources: Aesthetic Nurse

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Kelly Scientific Resources: Aesthetic Nurse . 45,000: Kelly Scientific Resources: VACANCY :    AESTHETIC NURSE Salary/ Package:    € 35k   – € 45k dependant on experience Contract:   Permanent  … Continue reading → Cet article #jobs #lifescience ...

HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics

The acquisition strengthens HiFiBiO Therapeutics’ strategic focus on identifying first-in-class targets for multiple immune cell types, as well as applying industry-leading technologies to develop diverse antibody therapeutics. Specific The post HiFiBiO Therapeutics buys early-stage biotech firm H-Immune Therapeutics appeared first on Pharma Business review.

Indalo Therapeutics Names Robert Jacks President & CEO

Indalo Therapeutics has appointed Robert Jacks to serve as president and CEO. Jacks was most recently president and chief financial officer of Symbiomix Therapeutics, which was acquired by Lupin in 2017. Indalo was formed by the 2016 merger of Antegrin Therapeutics and Cascadia Therapeutics. The Cambridge, MA-based company’s lead drug candidate, IDL-2965, is expected to […]

Boral Resources Commences Marketing of Previously Disposed Fly Ash

ATLANTA, Sept. 13, 2018 /PRNewswire/ -- Boral Resources has commenced harvesting and making available approximately 2 million tons of high-grade Class F pozzolan from a Read more...

AOHP, NIOSH Update Respirator Resources

The Association of Occupational Health Professionals in Healthcare has updated its Web Resources Guide, which includes links to all manner of regulations, guidelines, and training materials by federal agencies and healthcare organizations.

Lonestar Resources Announces Participation In Upcoming Conferences

FORT WORTH, Texas, Nov. 21, 2018 /PRNewswire/ -- Lonestar Resources US Inc. (NASDAQ: LONE) (together with its subsidiaries, "Lonestar") announced that its Chief Executive Officer, Read more...

Construction Resources Expands With Addition of New Lighting Showroom

ATLANTA, Sept. 17, 2018 /PRNewswire/ -- Construction Resources, an established family of design and construction supply businesses serving the Southeastern U.S., announces the opening of Read more...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks